Cyclophosphamide Induced Cystitis: Role of Nitric Oxide Synthase, Cyclooxygenase-1 and 2, and NK1 Receptors

Journal of Urology

Volumn 177, Issue 4, 2007, Pages 1531-1536

  Linares Fernández, Beatriz E ^a   Alfieri, Anna B ^b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

bladder; cyclophosphamide; cystitis; nitric oxide synthase; prostaglandin endoperoxide synthases

Indexed keywords

17ALPHA ETHYNYL 17BETA HYDROXY 5ALPHA ANDROSTANO[3,2 B]PYRIMIDO[1,2 A]BENZIMIDAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; KETOPROFEN; MELOXICAM; MYELOPEROXIDASE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2; ROFECOXIB; S METHYLTHIOUREA; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTITIS; CYTOTOXICITY; ENZYME ACTIVITY; EXTRAVASATION; HISTOLOGY; MALE; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYCLOPHOSPHAMIDE; CYSTITIS; MALE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 33947279387     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.11.072     Document Type: Article

References (19)

1. Korkmaz A., Oter S., Deveci S., Goksoy C., and Bilgic H. Prevention of further induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs. J Urol 166 (2001) 1119
2. Ahluwalia A., Maggi C.A., Santiccioli P., Lecci A., and Giuliani S. Characterizacion of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br J Pharmacol 111 (1994) 1017
3. 1-tachykinin receptors in cyclophosphamide-induced cystitis, in rats. J Pharmacol Exp Ther 295 (2000) 824
4. Ponte Souza-Filho M.V., Alves M.V., Lima M.M., Ballejo G., Queiroz F., and Ribeiro R. Involvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Am J Pathol 150: (1997) 247
5. Alfieri A.B., Malavé A., and Cubeddu L. Nitric oxide synthases and cyclophosphamide-induced cystitis in rats. Naunyn Mar 363 (2001) 353
6. 2 production are up-regulated in a rat bladder inflammation model. Eur J Pharmacol 417 (2001) 239
7. Saria A., and Lundberg J. Evans blue fluorescence quantitative and morphological evaluation of vascular permeability in animal tissue. J Neurosci Methods 8 (1983) 41
8. Palmer R.M., and Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 158 (1989) 348
9. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265
10. Stucchi, et al. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am J Physiol 279: (2000) G1298
11. Lang K. Eine mikromethode zur bestimmung des prolins und des oxyprolins. Z Physiol Chem 219 (1933) 148
12. Venkatesan N., Punithavathi D., and Chandrakasan G. Biochemical and connective tissue changes in cyclophosphamide induced lung fibrosis in rats. Biochem Pharmacol 156 (1998) 895
13. Costa S.K., Yshii L.M., Poston R.N., Muscará M., and Brain S.D. Pivotal role of endogenous tachykinins and the NK1 receptor in mediating leukocyte accumulation, in the absence of oedema formation, in response to TNFα in the cutaneous microvasculature. J Neuroimmunol 171 (2006) 99 Epub November 2, 2005.
14. Abu-Soud H., and Hazen S. Nitric oxide modulates the catalytic activity of myeloperoxidase. J Biol Chem 275 (2000) 5425
15. Hu V., Malley S., Dattilio A., Folsom J., Zvara P., and Vizzard M. COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat. Am J Physiol Regul Integr Comp Physiol 284 (2003) R574
16. Feldman M., and McMahon A. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?. Ann Intern Med 132 (2000) 134
17. Wallace J.L., Chapman K., and McKnight W. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation. Br J Pharmacol 126 (1999) 1200
18. Warner T., and Mitchell J. Cyclooxygenase-3 (COX-3): filling in the gaps towards a COX continuum?. PNAS 99 (2002) 13371
19. Ribeiro M., Cella M., Farina M., and Franchi A. Effects of aminoguanidine and cyclooxygenase inhibitors on nitric oxide and prostaglandin production, and nitric oxide synthase and cyclooxygenase expression induced by lipopolysaccharide in the estrogenized rat uterus. Neuroimmunomodulation 11 (2004) 191